AlloDx Presents Organ Transplant Liquid Biopsy Research at ATC 2018

The American Transplant Congress (ATC) was held in Seattle, USA, from June 1 to 6, 2018. Dr. Yang Gongda of the company was invited to attend this global event in organ transplantation and presented the team's latest research achievement, 'Noninvasive Detection of Infection and Rejection in Renal Transplant Patients,' at the congress, which drew widespread attention and recognition from attending experts. The related testing indicators also attracted expert interest and affirmation. The American Transplant Congress (ATC), the European Society for Organ Transplantation (ESOT), and The Transplantation Society (TTS) are the three most influential international academic organizations in organ transplantation, and each meeting serves as a stage for showcasing frontier research in the field. Rejection and infection in transplant patients are the main causes of graft loss, and precise, non-invasive, real-time clinical diagnosis is essential. After more than two years of process R&D optimization, case collection, and clinical follow-up, the company built China's first rejection and infection database for transplant populations.

This study is one of the few domestic research results included in the conference. It contributes to basic research in the field of organ transplantation in my country and strives to open a new era of organ transplantation research in China.